Browsing by Author Dasoula, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 15 of 15
TitleAuthor(s)Issue date
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasmsHatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L.24-Nov-2015
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaHatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L.24-Nov-2015
Absence of mutations of the EPO-receptor gene in Greek patients with familial polycythemiaBourantas, L. K.; Chatzikyriakidou, A.; Dasoula, A.; Syrrou, M.; Bournatas, K. L.; Georgiou, I.24-Nov-2015
Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson diseaseVoutsinas, G. E.; Stavrou, E. F.; Karousos, G.; Dasoula, A.; Papachatzopoulou, A.; Syrrou, M.; Verkerk, A. J.; van der Spek, P.; Patrinos, G. P.; Stoger, R.; Athanassiadou, A.24-Nov-2015
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implicationsHatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T.24-Nov-2015
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromesBenetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L.24-Nov-2015
Jun B Expression Is Associated with Non-GC (Germinal Center) B Cell Differentiation Immunophenotype, and Jun B and Jun D with High Proliferation of Tumor Cells in DLBCL.Papoudou-Bai, A.; Batistatou, A.; Hatzimichael, E.; Dasoula, A.; Kanavaros, P.; Malamou-Mitsi, V.24-Nov-2015
Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromesBenetatos, L.; Dasoula, A.; Syed, N.; Hatzimichael, E.; Crook, T.; Bourantas, K. L.24-Nov-2015
Methylation status of the SNRPN and HUMARA genes in testicular biopsy samplesDasoula, A.; Georgiou, I.; Kontogianni, E.; Sofikitis, N.; Syrrou, M.24-Nov-2015
Mosaic trisomy r(14) associated with epilepsy and mental retardationTzoufi, M.; Kanioglou, C.; Dasoula, A.; Asproudis, I.; Tsatsoulis, A.; Sismani, C.; Patsalis, P. C.; Georgiou, I.; Syrrou, M.24-Nov-2015
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactionsBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T.24-Nov-2015
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaHatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T.24-Nov-2015
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myelomaBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L.24-Nov-2015
Skewed X-chromosome inactivation in Greek women with idiopathic recurrent miscarriageDasoula, A.; Kalantaridou, S.; Sotiriadis, A.; Pavlou, M.; Georgiou, I.; Paraskevaidis, E.; Makrigiannakis, A.; Syrrou, M.24-Nov-2015
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseHatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L.24-Nov-2015